Anti-TNFα therapy in inflammatory lung diseases

被引：206

作者：

Malaviya, Rama ^{[1
]}

Laskin, Jeffrey D. ^{[2
]}

Laskin, Debra L. ^{[1
]}

机构：

[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmacol & Toxicol, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA

[2] Rutgers State Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Piscataway, NJ 08854 USA

来源：

PHARMACOLOGY & THERAPEUTICS | 2017年 / 180卷

基金：

美国国家卫生研究院;

关键词：

TNF; Pulmonary disease; Lung injury; Biologics; Inflammation; TUMOR-NECROSIS-FACTOR; IDIOPATHIC PULMONARY-FIBROSIS; RESPIRATORY-DISTRESS-SYNDROME; PLACEBO-CONTROLLED TRIAL; BRONCHIAL EPITHELIAL-CELLS; RECEPTOR FUSION PROTEIN; FACTOR-KAPPA-B; ALVEOLAR MACROPHAGES; DOUBLE-BLIND; MONOCLONAL-ANTIBODY;

D O I：

10.1016/j.pharmthera.2017.06.008

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Increased levels of tumor necrosis factor (TNF) alpha have been linked to a number of pulmonary inflammatory diseases including asthma, chronic obstructive pulmonary disease (COPD), acute lung injury (ALI)/acute respiratory distress syndrome (ARDS), sarcoidosis, and interstitial pulmonary fibrosis (IPF). TNF alpha plays multiple roles in disease pathology by inducing an accumulation of inflammatory cells, stimulating the generation of inflammatory mediators, and causing oxidative and nitrosative stress, airway hyperresponsiveness and tissue remodeling. TNF alpha-targeting biologics, therefore, present a potentially highly efficacious treatment option. This review summarizes current knowledge on the role of TNFa in pulmonary disease pathologies, with a focus on the therapeutic potential of TNF alpha-targeting agents in treating inflammatory lung diseases. (C) 2017 Elsevier Inc. All rights reserved.

引用

页码：90 / 98

页数：9

共 181 条

[51] Regulation of caveolin-1 expression, nitric oxide production and tissue injury by tumor necrosis factor-α following ozone inhalation [J].

Fakhrzadeh, Ladan ;

Laskin, Jeffrey D. ;

Laskin, Debra L. .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 2008, 227 (03) :380-389

[52] Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease - A randomized placebo-controlled study [J].

Fernandes, Juliano Lara ;

Dias de Oliveira, Rornulo Tadeu ;

Mamoni, Ronei Luciano ;

Coelho, Otavio Rizzi ;

Nicolau, Jose Carlos ;

Blotta, Maria Heloisa S. L. ;

Serrano, Carlos Vicente, Jr. .

ATHEROSCLEROSIS, 2008, 196 (01) :434-442

[53]

FINOTTO S, 1994, J IMMUNOL, V153, P2278

[54] Overexpression of tumor necrosis factor-α produces an increase in lung volumes and pulmonary hypertension [J].

Fujita, M ;

Shannon, JM ;

Irvin, CG ;

Fagan, KA ;

Cool, C ;

Augustin, A ;

Mason, RJ .

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2001, 280 (01) :L39-L49

[55] Evaluation of inflammatory cytokine secretion by human alveolar macrophages [J].

García, JEL ;

Rodríguez, FM ;

de Cabo, MRM ;

Salgado, MJG ;

Losada, JP ;

Villarón, LG ;

López, AJ ;

Arellano, JLP .

MEDIATORS OF INFLAMMATION, 1999, 8 (01) :43-51

[56] Defective TNF-α-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice [J].

García-Ruiz, C ;

Colell, A ;

Marí, M ;

Morales, A ;

Calvo, M ;

Enrich, C ;

Fernández-Checa, JC .

JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (02) :197-208

[57] Reactive oxygen intermediates in TNF signaling [J].

Garg, AK ;

Aggarwal, BB .

MOLECULAR IMMUNOLOGY, 2002, 39 (09) :509-517

[58]

Gossart S, 1996, J IMMUNOL, V156, P1540

[59] INCREASED SECRETION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-6 BY ALVEOLAR MACROPHAGES CONSECUTIVE TO THE DEVELOPMENT OF THE LATE ASTHMATIC REACTION [J].

GOSSET, P ;

TSICOPOULOS, A ;

WALLAERT, B ;

VANNIMENUS, C ;

JOSEPH, M ;

TONNEL, AB ;

CAPRON, A .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (04) :561-571

[60]

Grau GE, 1996, LAB INVEST, V74, P761

← 1 2 3 4 5 6 7 8 9 10 →